ANDREA WISE: Open Payments
NPI 1417462151 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $150 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $85 |
| ANI Pharmaceuticals, Inc. | 3 | $77 |
| Amgen Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Dexcom G6 Transmitter, PURIFIED CORTROPHIN GEL, KRYSTEXXA, Fabhalta, TAVNEOS, TARPEYO, Ozempic, JARDIANCE.
Industry payments across KS — which companies pay providers there.
